×
About 4,167 results

ALLMedicine™ Gallbladder Cancer Center

Research & Reviews  2,031 results

An intact boundary between the tumor and inner hypoechoic layer discriminates T1 lesion...
https://doi.org/10.1002/jhbp.961
Journal of Hepato-biliary-pancreatic Sciences; Toyonaga H, Hayashi T et. al.

Apr 7th, 2021 - The depth of invasion determines the surgical method for treating gallbladder cancer (GBC). However, the preoperative correct diagnosis of invasion depth, especially discrimination of T1 lesions among sessile elevated GBCs, is difficult. We invest...

TUBB3 Promotes Growth and Invasion of Gallbladder Cancer Cells by Akt/mTOR Signal Pathway.
https://doi.org/10.1615/JEnvironPatholToxicolOncol.2021036821
Journal of Environmental Pathology, Toxicology and Oncolo... Liu Z, Li S et. al.

Apr 6th, 2021 - Aberrant expression of β-tubulin-III (TUBB3) is known that related to aggressive tumor features and poor clinical outcomes. However, there is limited research about TUBB3 expression and its role in the outcomes and the progression of gallbladder c...

Robotic Completion Radical Cholecystectomy with Fluorescence Guidance.
https://doi.org/10.1245/s10434-021-09819-w
Annals of Surgical Oncology; Newton AD, Newhook TE et. al.

Mar 28th, 2021 - The application of minimally invasive surgery (MIS) techniques in the treatment of hepatobiliary malignancies offers advantages of shorter length of stay, quicker functional recovery, and decreased need for postoperative opioids. However, MIS comp...

Mutational spectrum and precision oncology for biliary tract carcinoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978308
Theranostics Lin J, Cao Y et. al.

Mar 23rd, 2021 - Background: The genomic spectrum of biliary tract carcinoma (BTC) has been characterized and is associated with distinct anatomic and etiologic subtypes, yet limited studies have linked genomic alterations with personalized therapies in BTC patien...

Fork head box M1 regulates vascular endothelial growth factor-A expression to promote t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934001
World Journal of Gastroenterology; Wang RT, Miao RC et. al.

Mar 15th, 2021 - Gallbladder cancer (GBC) is an aggressive type of biliary tract cancer that lacks effective therapeutic targets. Fork head box M1 (FoxM1) is an emerging molecular target associated with tumor progression in GBC, and accumulating evidence suggests ...

see more →

Guidelines  9 results

AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With...
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.

Jul 15th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
http://ascopubs.org/doi/full/10.1200/JCO.18.02178

Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(18)30267-6/fulltext
Sung,H.,et al

Feb 2nd, 2019 - Cancer trends in younger adults, often under 50 years, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden. Previous studies reported an increase in early onset colorectal cancer, which could ...

Gallbladder cancer: expert consensus statement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527853
HPB : the Official Journal of the International Hepato Pa... Aloia TA, Járufe N et. al.

Jul 14th, 2015 - An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists was convened on 15 January 2014 to review current evidence on the management of gallbladder carcinoma in order to establish practice guidelin...

see more →

Clinicaltrials.gov  2,081 results

An intact boundary between the tumor and inner hypoechoic layer discriminates T1 lesion...
https://doi.org/10.1002/jhbp.961
Journal of Hepato-biliary-pancreatic Sciences; Toyonaga H, Hayashi T et. al.

Apr 7th, 2021 - The depth of invasion determines the surgical method for treating gallbladder cancer (GBC). However, the preoperative correct diagnosis of invasion depth, especially discrimination of T1 lesions among sessile elevated GBCs, is difficult. We invest...

TUBB3 Promotes Growth and Invasion of Gallbladder Cancer Cells by Akt/mTOR Signal Pathway.
https://doi.org/10.1615/JEnvironPatholToxicolOncol.2021036821
Journal of Environmental Pathology, Toxicology and Oncolo... Liu Z, Li S et. al.

Apr 6th, 2021 - Aberrant expression of β-tubulin-III (TUBB3) is known that related to aggressive tumor features and poor clinical outcomes. However, there is limited research about TUBB3 expression and its role in the outcomes and the progression of gallbladder c...

Robotic Completion Radical Cholecystectomy with Fluorescence Guidance.
https://doi.org/10.1245/s10434-021-09819-w
Annals of Surgical Oncology; Newton AD, Newhook TE et. al.

Mar 28th, 2021 - The application of minimally invasive surgery (MIS) techniques in the treatment of hepatobiliary malignancies offers advantages of shorter length of stay, quicker functional recovery, and decreased need for postoperative opioids. However, MIS comp...

Mutational spectrum and precision oncology for biliary tract carcinoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978308
Theranostics Lin J, Cao Y et. al.

Mar 23rd, 2021 - Background: The genomic spectrum of biliary tract carcinoma (BTC) has been characterized and is associated with distinct anatomic and etiologic subtypes, yet limited studies have linked genomic alterations with personalized therapies in BTC patien...

Fork head box M1 regulates vascular endothelial growth factor-A expression to promote t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934001
World Journal of Gastroenterology; Wang RT, Miao RC et. al.

Mar 15th, 2021 - Gallbladder cancer (GBC) is an aggressive type of biliary tract cancer that lacks effective therapeutic targets. Fork head box M1 (FoxM1) is an emerging molecular target associated with tumor progression in GBC, and accumulating evidence suggests ...

see more →

News  31 results

Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/internalmedicine/article/209796/hepatology/surveillance-hepatobiliary-cancers-primary-sclerosing?channel=75
Bianca Nogrady

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical update published in Clinical G.

AGA CPU: Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/gihepnews/article/209796/hepatology/aga-cpu-surveillance-hepatobiliary-cancers-primary-sclerosing?channel=346
Bianca Nogrady, MDedge News

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical update published in Clinical G.

AGA Clinical Practice Update: Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/gihepnews/article/209796/hepatology/aga-clinical-practice-update-surveillance-hepatobiliary-cancers?channel=346
Bianca Nogrady, MDedge News

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical practice update published in C.

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
http://ascopubs.org/doi/full/10.1200/JCO.18.02178

Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

see more →

Patient Education  15 results see all →